SLNO logo

Soleno Therapeutics, Inc. (SLNO)

Profile

Full Name

Soleno Therapeutics, Inc.

Ticker

NASDAQ: SLNO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 13, 2014

Indexes

Not included

Website

http://soleno.life

Employees

115

Key Details

Price

$80.32(-9.23%)

Market cap

$4.05B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$4.38(-85.59% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $80.32
    SLNO price is $80.32

    30-Day Relative Volume

    4.94
    SLNO 30-day relative volume is 4.94

    Price Performance

    Price Most recent change

    -9.23%
    SLNO price was down -9.23% on Jul 10, 2025

    Price YTD change

    +78.69%
    SLNO price is up +78.69% since January 1st

    Price 1-year change

    +86.83%
    SLNO price is up +86.83% year-on-year

    Price 3-year change

    +2390.54%
    SLNO price is up +2390.54% over the past 3 years

    Price Range

    Price All-time high

    $742.50
    SLNO price is currently -89.18% below its historical high of $742.50

    Price 3-year low

    $0.85
    SLNO price is currently +9349.41% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $4.05B
    SLNO market capitalization is $4.05 billion

    Market cap 3-year change

    +15576.96%
    SLNO market capitalization is up +15576.96% over the past 3 years

    Market cap All-time high

    $4.46B
    SLNO market capitalization is currently -9.23% below its historical high of $4.46 billion

    Market cap sector rank

    87.69%
    SLNO market capitalization is higher than 87.69% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +31.28%
    SLNO shares outstanding is up +31.28% year-on-year

    Shares Outstanding 3-Year Change

    +529.46%
    SLNO shares outstanding is up +529.46% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.00
    SLNO beta is 1.00

    200-day SMA

    $59.08
    SLNO price is currently +35.94% above its 200-day simple moving average

    50-day SMA

    $78.36
    SLNO price is currently +2.50% above its 50-day simple moving average

    RSI

    47.62
    SLNO 14-day relative strength index is 47.62

    Volume

    4.94
    SLNO 30-day relative volume is 4.94

    ATR

    $3.39
    SLNO average true range is $3.39

    10-day Historical Volatility

    59.16%
    SLNO 10-day historical volatility is 59.16%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    SLNO annual revenue value is unknown

    Revenue Analysts estimate

    $48.36M
    SLNO annual revenue is currently equal to the consensus analysts' forecast

    Revenue 1-year change

    -
    SLNO annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    SLNO annual revenue is unknown

    EPS

    EPS

    -$4.38
    SLNO annual earnings per share is -$4.38

    EPS Analysts estimate

    -
    SLNO annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -85.59%
    SLNO annual earnings per share is down -85.59% year-on-year

    EPS Sector rank

    21.93%
    SLNO annual earnings per share is higher than 21.93% of companies in Healthcare sector

    Profit

    Gross profit

    -
    SLNO annual gross profit value is unknown

    Gross margin

    -
    SLNO annual gross profit margin value is unknown

    Operating profit

    -$184.43M
    SLNO annual operating income is -$184.43 million

    Operating margin

    -
    SLNO annual operating profit margin value is unknown

    Net income

    -$175.85M
    SLNO annual net profit is -$175.85 million

    Net margin

    -
    SLNO annual net profit margin value is unknown

    Expenses

    Total expenses

    $184.43M
    SLNO annual total expenses is $184.43 million

    Operating expenses

    $184.43M
    SLNO annual total operating expenses is $184.43 million

    Cost of goods sold

    -
    SLNO annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $105.86M
    SLNO annual SGA is $105.86 million

    Depreciation and amortization

    $1.99M
    SLNO annual depreciation & amortization is $1.99 million

    Interest expense

    $231.00K
    SLNO annual interest expense is $231.00 thousand

    Income tax

    -
    SLNO annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$175.62M
    SLNO annual earnings before interest & taxes is -$175.62 million

    EBITDA

    -$173.63M
    SLNO annual EBITDA is -$173.63 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $330.97M
    SLNO annual total assets is $330.97 million

    Non current assets

    $37.08M
    SLNO annual long term assets is $37.08 million

    Current assets

    $293.89M
    SLNO annual total current assets is $293.89 million

    Cash and cash equivalents

    $87.93M
    SLNO annual cash & cash equivalents is $87.93 million

    Accounts receivable

    -
    SLNO annual accounts receivable value is unknown

    Inventory

    -
    SLNO annual inventory value is unknown

    Liabilities

    Total liabilities

    $85.86M
    SLNO annual total liabilities is $85.86 million

    Long term liabilities

    $67.11M
    SLNO annual total long term liabilities is $67.11 million

    Current liabilities

    $18.75M
    SLNO annual total current liabilities is $18.75 million

    Accounts payable

    $8.88M
    SLNO annual accounts payable is $8.88 million

    Debt

    Total debt

    $52.83M
    SLNO annual total debt is $52.83 million

    Total debt 1-year change

    +13008.19%
    SLNO annual total debt is up +13008.19% year-on-year

    Long term debt

    $52.30M
    SLNO annual long term debt is $52.30 million

    Short term debt

    $526.00K
    SLNO annual short term debt is $526.00 thousand

    Equity & Capital

    Shareholders equity

    $245.11M
    SLNO annual stockholders equity is $245.11 million

    Book value

    $245.11M
    SLNO annual book value is $245.11 million

    Retained earnings

    -$452.26M
    SLNO annual retained earnings is -$452.26 million

    Working capital

    $275.14M
    SLNO annual working capital is $275.14 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$69.10M
    SLNO annual cash flow from operations is -$69.10 million

    Cash from operations 1-year change

    -177.05%
    SLNO annual cash flow from operations is down -177.05% year-on-year

    Cash from investing

    -$225.68M
    SLNO annual cash flow from investing activities is -$225.68 million

    Cash from investing 1-year change

    -100%
    SLNO annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    $213.03M
    SLNO annual cash flow from financing activities is $213.03 million

    Cash from financing 1-year change

    +18.33%
    SLNO annual cash flow from financing activities is up +18.33% year-on-year

    CAPEX

    CAPEX

    -
    SLNO annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    SLNO annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$69.31M
    SLNO annual free cash flow is -$69.31 million

    Free cash flow 1-year change

    -177.92%
    SLNO annual free cash flow is down -177.92% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    SLNO annual gross profit margin value is unknown

    Operating margin

    -
    SLNO annual operating profit margin value is unknown

    Net margin

    -
    SLNO annual net profit margin value is unknown

    ROA & ROE

    ROA

    -53.13%
    SLNO annual return on assets is -53.13%

    ROE

    -71.74%
    SLNO annual return on equity is -71.74%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SLNO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SLNO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    17.43
    SLNO price to book ratio is 17.43

    PB ratio Sector rank

    94.38%
    SLNO price to book ratio is higher than 94.38% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    SLNO price to sales ratio value is unknown

    PS ratio Sector rank

    -
    SLNO price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $4.02B
    SLNO enterprise value is $4.02 billion

    Enterprise value Sector rank

    86.25%
    SLNO enterprise value is higher than 86.25% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -20.77
    SLNO EV/EBITDA is -20.77

    EV/EBITDA Sector rank

    7.3%
    SLNO EV/EBITDA is higher than 7.3% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    15.68
    SLNO annual current ratio is 15.68

    Quick ratio

    -
    SLNO annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.22
    SLNO annual debt to equity ratio is 0.22

    Interest coverage ratio

    -760.26
    SLNO annual interest coverage ratio is -760.26

    Risk & Stability

    Piotroski F-Score

    -
    SLNO piotroski f-score value is unknown

    Altman Z-Score

    -
    SLNO altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    May 8, 25 Guggenheim
    Buy
    May 8, 25 Baird
    Outperform
    Apr 24, 25 Piper Sandler
    Overweight
    Apr 15, 25 HC Wainwright & Co.
    Buy
    Mar 31, 25 HC Wainwright & Co.
    Buy
    Mar 28, 25 Stifel
    Buy
    Mar 28, 25 Guggenheim
    Buy
    Mar 27, 25 Laidlaw & Co.
    Buy
    Mar 27, 25 Cantor Fitzgerald
    Overweight
    Mar 27, 25 Baird
    Outperform

    Institutional Ownership

    Screeners with SLNO included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Soleno Therapeutics, Inc.?
    • Does Soleno Therapeutics, Inc. pay dividends?
    • What sector is Soleno Therapeutics, Inc. in?
    • What industry is Soleno Therapeutics, Inc. in?
    • What country is Soleno Therapeutics, Inc. based in?
    • When did Soleno Therapeutics, Inc. go public?
    • Is Soleno Therapeutics, Inc. in the S&P 500?
    • Is Soleno Therapeutics, Inc. in the NASDAQ 100?
    • Is Soleno Therapeutics, Inc. in the Dow Jones?
    • When was Soleno Therapeutics, Inc.'s last earnings report?
    • When does Soleno Therapeutics, Inc. report earnings?

    What is the ticker symbol for Soleno Therapeutics, Inc.?

    The ticker symbol for Soleno Therapeutics, Inc. is NASDAQ:SLNO

    Does Soleno Therapeutics, Inc. pay dividends?

    No, Soleno Therapeutics, Inc. does not pay dividends

    What sector is Soleno Therapeutics, Inc. in?

    Soleno Therapeutics, Inc. is in the Healthcare sector

    What industry is Soleno Therapeutics, Inc. in?

    Soleno Therapeutics, Inc. is in the Biotechnology industry

    What country is Soleno Therapeutics, Inc. based in?

    Soleno Therapeutics, Inc. is headquartered in United States

    When did Soleno Therapeutics, Inc. go public?

    Soleno Therapeutics, Inc.'s initial public offering (IPO) was on November 13, 2014

    Is Soleno Therapeutics, Inc. in the S&P 500?

    No, Soleno Therapeutics, Inc. is not included in the S&P 500 index

    Is Soleno Therapeutics, Inc. in the NASDAQ 100?

    No, Soleno Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Soleno Therapeutics, Inc. in the Dow Jones?

    No, Soleno Therapeutics, Inc. is not included in the Dow Jones index

    When was Soleno Therapeutics, Inc.'s last earnings report?

    Soleno Therapeutics, Inc.'s most recent earnings report was on May 7, 2025

    When does Soleno Therapeutics, Inc. report earnings?

    The next expected earnings date for Soleno Therapeutics, Inc. is August 7, 2025
    On this page